137 related articles for article (PubMed ID: 33316798)
1. Role of Cytology in the Current Guidelines for Malignant Mesothelioma: Largest Study from India.
Kaur K; Patel T; Samanta S; Patra S; Trivedi P
Acta Cytol; 2021; 65(2):175-185. PubMed ID: 33316798
[TBL] [Abstract][Full Text] [Related]
2. Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: Ten Years of Clinical Experience in Relation to International Guidelines.
Hjerpe A; Abd-Own S; Dobra K
Arch Pathol Lab Med; 2018 Aug; 142(8):893-901. PubMed ID: 30040460
[TBL] [Abstract][Full Text] [Related]
3. The role of BRCA1-associated protein 1 in the diagnosis of malignant mesothelioma in effusion and fine-needle aspiration cytology.
Hatem L; McIntire PJ; He B; Gogineni S; Ho M; Mathew S; Margolskee EM; Siddiqui MT; Rao RA
Diagn Cytopathol; 2019 Mar; 47(3):160-165. PubMed ID: 30520251
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary statement from the international mesothelioma interest group, also endorsed by the international academy of cytology and the papanicolaou society of cytopathology. A proposal to be applauded and promoted but which requires updating.
Sheaff M
Diagn Cytopathol; 2020 Oct; 48(10):877-879. PubMed ID: 31976625
[TBL] [Abstract][Full Text] [Related]
5. The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas.
Prabhakaran S; Hocking A; Kim C; Hussey M; Klebe S
Hum Pathol; 2020 Nov; 105():1-8. PubMed ID: 32888937
[TBL] [Abstract][Full Text] [Related]
6. Combined grade and nuclear grade are prognosis predictors of epithelioid malignant peritoneal mesothelioma: a multi-institutional retrospective study.
Benzerdjeb N; Dartigues P; Kepenekian V; Valmary-Degano S; Mery E; Averous G; Chevallier A; Laverriere MH; Villa I; Sallé FG; Villeneuve L; Glehen O; Isaac S; Hommell-Fontaine J;
Virchows Arch; 2021 Nov; 479(5):927-936. PubMed ID: 34169365
[TBL] [Abstract][Full Text] [Related]
7. GATA3 is a useful immunohistochemical marker for distinguishing sarcomatoid malignant mesothelioma from lung sarcomatoid carcinoma and organizing pleuritis.
Piao ZH; Zhou XC; Chen JY
Virchows Arch; 2021 Aug; 479(2):257-263. PubMed ID: 33570661
[TBL] [Abstract][Full Text] [Related]
8. Effusion cytology of malignant mesothelioma enables earlier diagnosis and recognizes patients with better prognosis.
Abd Own S; Höijer J; Hillerdahl G; Dobra K; Hjerpe A
Diagn Cytopathol; 2021 May; 49(5):606-614. PubMed ID: 32049443
[TBL] [Abstract][Full Text] [Related]
9. Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens.
Hwang HC; Sheffield BS; Rodriguez S; Thompson K; Tse CH; Gown AM; Churg A
Am J Surg Pathol; 2016 Jan; 40(1):120-6. PubMed ID: 26448191
[TBL] [Abstract][Full Text] [Related]
10. Malignant mesothelioma: A clinicopathological study of 76 cases with emphasis on immunohistochemical evaluation along with review of the literature.
Patel T; Aswal P
Indian J Pathol Microbiol; 2021; 64(4):655-663. PubMed ID: 34673582
[TBL] [Abstract][Full Text] [Related]
11. Testing for BAP1 loss and CDKN2A/p16 homozygous deletion improves the accurate diagnosis of mesothelial proliferations in effusion cytology.
Chevrier M; Monaco SE; Jerome JA; Galateau-Salle F; Churg A; Dacic S
Cancer Cytopathol; 2020 Dec; 128(12):939-947. PubMed ID: 32678499
[TBL] [Abstract][Full Text] [Related]
12. miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology.
Cappellesso R; Galasso M; Nicolè L; Dabrilli P; Volinia S; Fassina A
Cancer Cytopathol; 2017 Aug; 125(8):635-643. PubMed ID: 28449331
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience.
Loveland P; Christie M; Hammerschlag G; Irving L; Steinfort D
Intern Med J; 2018 Nov; 48(11):1318-1324. PubMed ID: 29869427
[TBL] [Abstract][Full Text] [Related]
14. Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry.
Sandeck HP; Røe OD; Kjærheim K; Willén H; Larsson E
Diagn Pathol; 2010 Jul; 5():47. PubMed ID: 20602796
[TBL] [Abstract][Full Text] [Related]
15. How to assess the best immunohistochemical panel in the diagnosis of malignant pleural mesothelioma in a pathology lab.
Mlika M; Lamzibri O; Bacha S; Laabidi S; Haddouchi C; Mezni FE
J Immunoassay Immunochem; 2018; 39(3):263-273. PubMed ID: 29757709
[TBL] [Abstract][Full Text] [Related]
16. Malignant mesothelioma: A histomorphological and immunohistochemical study of 24 cases from a tertiary care hospital in Southern India.
Hui M; Uppin SG; Bhaskar K; Kumar NN; Paramjyothi GK
Indian J Cancer; 2018; 55(2):190-195. PubMed ID: 30604735
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology.
Hjerpe A; Ascoli V; Bedrossian C; Boon M; Creaney J; Davidson B; Dejmek A; Dobra K; Fassina A; Field A; Firat P; Kamei T; Kobayashi T; Michael CW; Önder S; Segal A; Vielh P
Cytojournal; 2015; 12():26. PubMed ID: 26681974
[TBL] [Abstract][Full Text] [Related]
18. Epithelioid angiosarcoma at chest wall which needs to be carefully distinguished from malignant mesothelioma: report of a rare case.
Fan C; Liu Y; Lin X; Han Y; He A; Wang E
Int J Clin Exp Pathol; 2014; 7(12):9056-60. PubMed ID: 25674287
[TBL] [Abstract][Full Text] [Related]
19. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens.
Berg KB; Churg AM; Cheung S; Dacic S
Cancer Cytopathol; 2020 Feb; 128(2):126-132. PubMed ID: 31821740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
